BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND KDSR, Q06136, 2531, ENSG00000119537, FVT1
5 results:

  • 1. Clinical significance of immunohistochemistry to detect BRAF V600E mutant protein in thyroid tissues.
    Zhang Y; Liu L; Liu Y; Cao N; Wang L; Xing C
    Medicine (Baltimore); 2021 Apr; 100(16):e25566. PubMed ID: 33879712
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparison of 5-tiered and 6-tiered diagnostic systems for the reporting of thyroid cytopathology: a multi-institutional study.
    Bongiovanni M; Crippa S; Baloch Z; Piana S; Spitale A; Pagni F; Mazzucchelli L; Di Bella C; Faquin W
    Cancer Cytopathol; 2012 Apr; 120(2):117-25. PubMed ID: 21998003
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparison of positron emission tomography with [(18)F]FDG and [(68)Ga]DOTATOC in recurrent differentiated thyroid cancer: preliminary data.
    Middendorp M; Selkinski I; Happel C; Kranert WT; Grünwald F
    Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):76-83. PubMed ID: 20168289
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Can quantitative diffusion-weighted MR imaging differentiate benign and malignant cold thyroid nodules? Initial results in 25 patients.
    Schueller-Weidekamm C; Kaserer K; Schueller G; Scheuba C; Ringl H; Weber M; Czerny C; Herneth AM
    AJNR Am J Neuroradiol; 2009 Feb; 30(2):417-22. PubMed ID: 18945798
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Promoter region of the rat gene encoding ornithine aminotransferase: transcriptional activity, sequence, and DNase-I-hypersensitive sites.
    Shull JD; Pennington KL; Rader AE
    Gene; 1993 Mar; 125(2):169-75. PubMed ID: 8462871
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.